COMMITMENTS AND CONTINGENCIES

9 Months Ended

Nov. 30, 2011

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 12 – COMMITMENTS AND CONTINGENCIES

Concentration Risk

In the nine months ended November 30, 2011, we sold AuraGen related products to four significant customers whose sales comprised 35%, 33%, 25% and 15% of net sales, respectively. Net accounts receivable from these customers at November 30, 2011 were $47,936, $152,175, $155,035 and $21,843 respectively. These customers are not related to or affiliated with us. In the nine months ended November 30, 2010, we sold AuraGen related products to four significant customers whose sales comprised 26%, 24%, 19% and 11% of net sales, respectively.  These customers are not related to or affiliated with us.